Senti Biosciences

formerly Senti BioIPO

Home - Senti Bio

Public · South San Francisco, United States · Founded 2016 · $205.6M raised

Employees
51–200
Founded
2016
Business Model
B2B
Total Funding
$205.6M
Last Round
$47.6M Corporate RoundDec 2024
Rounds
4
Type
Public

About

Senti Biosciences is a clinical-stage biotechnology company developing next-generation cell and gene therapies using proprietary Gene Circuit technology. Founded in 2016 and headquartered in South San Francisco, California, Senti Bio programs synthetic biology logic gates into cells to create smarter medicines for oncology and other incurable diseases.

Summary

Senti Biosciences is a Biotech company based in South San Francisco, United States, founded in 2016. It has raised $205.6M in total across 4 rounds, most recently a $47.6M Corporate Round round in Dec 2024. Investors include Celadon Partners, New Enterprise Associates and Leaps by Bayer.

Tech & App Stack

5 technologies & apps tracked

Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.

Sign up to view the funding chart

Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

Corporate RoundCorporate RoundDec 2024
$47.6M

Sign up to see all 4 rounds

Full funding history, per-round amounts, and investor participation.

Investors

Similar Companies